PatientID,record_date,ivf_result,sperm_result,embryo_grade,AMH,FSH,age,doctor_id,notes,Unnamed: 10,PIN
P10001,10/18/2025,successful,azoospermia,C,0.69,22.6,23,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6013
P10002,2/12/2025,failed,very low count,A,1,9.1,32,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,8215
P10003,8/22/2025,successful,azoospermia,A,5.28,10.1,22,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8478
P10004,11/4/2024,successful,normal,A,4.02,4,22,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8398
P10005,4/7/2025,failed,very low count,,5.04,19.5,32,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9761
P10006,7/31/2025,ongoing,not_tested,C,0.12,22.4,42,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9766
P10007,11/28/2024,failed,not_tested,,3.15,11.1,38,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9578
P10008,10/23/2024,failed,normal,,3.97,5.1,32,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9350
P10009,10/7/2025,failed,azoospermia,C,0.15,15.1,42,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6194
P10010,11/7/2025,ongoing,low count,,3.22,18.4,23,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6272
P10011,3/5/2025,ongoing,low count,,5.89,4.7,39,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,1826
P10012,5/4/2025,failed,normal,A,0.85,5.6,30,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6924
P10013,11/28/2024,successful,azoospermia,,0.05,15.8,38,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,119
P10014,11/16/2024,successful,azoospermia,A,4.78,10.1,39,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2439
P10015,10/30/2025,ongoing,very low count,,0.25,14.5,35,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8029
P10016,11/1/2025,failed,low count,,0.43,21.9,26,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9458
P10017,12/6/2024,successful,normal,A,4.56,10.3,31,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2584
P10018,12/13/2024,failed,very low count,,2.24,13.8,32,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2683
P10019,12/26/2024,successful,not_tested,,2.62,18.8,36,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4094
P10020,5/19/2025,successful,azoospermia,C,2.6,19.6,27,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8524
P10021,2/22/2025,failed,low count,C,3.03,14.1,33,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7404
P10022,1/26/2025,successful,very low count,B,1.26,8.7,34,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3205
P10023,3/2/2025,successful,low count,B,4.56,22.4,22,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1284
P10024,6/29/2025,failed,normal,C,0.55,14.3,26,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4535
P10025,3/11/2025,failed,azoospermia,A,1.58,21,40,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7502
P10026,5/23/2025,successful,low count,B,3.68,1.1,41,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8677
P10027,5/22/2025,failed,normal,A,2.2,12.1,43,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3209
P10028,6/5/2025,successful,azoospermia,C,4.88,5.6,27,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9782
P10029,10/13/2025,ongoing,azoospermia,C,4.98,5.2,39,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,7094
P10030,5/9/2025,successful,very low count,A,5.45,13.1,41,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3185
P10031,10/16/2025,ongoing,normal,,1.83,12.2,44,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,2418
P10032,7/12/2025,failed,very low count,,3.4,9.3,44,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2997
P10033,3/2/2025,failed,very low count,C,5.73,5.4,22,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7003
P10034,12/10/2024,failed,low count,,3.23,12.3,39,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3867
P10035,5/31/2025,ongoing,low count,A,2.81,22.6,41,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9670
P10036,11/17/2024,failed,normal,C,4.39,6.5,24,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7178
P10037,6/21/2025,successful,azoospermia,C,2.58,15.6,37,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7801
P10038,8/4/2025,successful,not_tested,B,4.59,23.2,28,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4997
P10039,3/3/2025,ongoing,azoospermia,B,1.73,3.2,36,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,1631
P10040,8/6/2025,failed,normal,,2.47,20,25,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9132
P10041,1/26/2025,successful,azoospermia,C,0.97,4.2,28,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,5128
P10042,10/25/2025,successful,low count,A,2.45,1.6,35,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3753
P10043,2/6/2025,successful,low count,,4.21,23.3,31,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2794
P10044,6/22/2025,failed,very low count,B,3.12,19,26,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7753
P10045,7/21/2025,successful,not_tested,,2.37,5.5,24,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4122
P10046,10/23/2025,successful,azoospermia,A,0.8,12,33,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9116
P10047,3/31/2025,failed,very low count,C,1.32,23.5,25,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2915
P10048,1/14/2025,failed,normal,B,5.76,5.3,26,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,1845
P10049,9/3/2025,ongoing,normal,B,4.74,3.1,23,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8612
P10050,8/31/2025,successful,azoospermia,B,3.98,2.4,26,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4694
P10051,3/22/2025,failed,low count,A,2.19,23.9,28,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6221
P10052,7/16/2025,failed,very low count,B,0.58,1.2,32,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6334
P10053,5/21/2025,failed,normal,A,3.32,3.6,29,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4063
P10054,7/16/2025,successful,normal,C,5.5,24.4,39,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8204
P10055,5/8/2025,failed,azoospermia,A,3.64,9.4,44,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,8855
P10056,5/18/2025,failed,normal,C,0.53,18.3,41,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,1623
P10057,3/31/2025,ongoing,not_tested,B,2.42,17.3,28,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,689
P10058,11/9/2024,successful,azoospermia,C,3.94,14.3,39,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3254
P10059,4/29/2025,successful,normal,B,4.69,9.8,25,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1400
P10060,11/13/2024,failed,very low count,A,5.36,2.8,23,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9733
P10061,5/13/2025,successful,azoospermia,A,3.75,13.5,39,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8194
P10062,12/7/2024,failed,very low count,C,4.81,16.3,43,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5806
P10063,4/2/2025,ongoing,normal,A,5.04,15.9,36,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6305
P10064,5/14/2025,ongoing,low count,B,2.36,11,29,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6683
P10065,4/14/2025,successful,normal,B,3.24,11.1,34,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3529
P10066,10/11/2025,ongoing,normal,,1.63,2.3,43,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,7406
P10067,6/8/2025,successful,not_tested,C,5.96,17,31,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9903
P10068,8/3/2025,successful,azoospermia,A,2.57,21.8,26,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3603
P10069,12/7/2024,successful,low count,A,2.72,24.2,34,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8930
P10070,11/14/2024,failed,very low count,A,5.67,21.7,24,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,1065
P10071,10/23/2025,ongoing,very low count,A,1.29,1.9,42,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9575
P10072,11/13/2024,successful,azoospermia,,3.71,9,27,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2387
P10073,4/8/2025,failed,normal,A,0.31,4.7,42,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9639
P10074,10/9/2024,failed,not_tested,C,2.22,11.1,30,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5603
P10075,4/17/2025,ongoing,not_tested,A,5.95,23.2,40,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6144
P10076,2/20/2025,failed,not_tested,A,2.75,16.7,42,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,1284
P10077,10/29/2025,successful,azoospermia,C,3.9,7.8,39,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1986
P10078,8/4/2025,successful,very low count,A,3.54,12.8,33,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,914
P10079,12/9/2024,successful,normal,A,1.43,10.2,26,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3055
P10080,10/19/2024,ongoing,not_tested,B,5.28,20.1,37,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,1253
P10081,6/5/2025,ongoing,azoospermia,C,2.06,12.5,29,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8752
P10082,11/5/2024,failed,normal,B,2.25,2,26,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4973
P10083,11/28/2024,failed,low count,B,3.08,16.7,37,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4954
P10084,3/18/2025,successful,very low count,,1.39,11.2,37,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8098
P10085,6/3/2025,successful,azoospermia,,4.2,24.5,36,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6475
P10086,11/6/2025,successful,very low count,C,1.96,6.7,44,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3754
P10087,11/5/2024,failed,not_tested,C,4.01,1.8,26,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6926
P10088,8/2/2025,ongoing,azoospermia,,3.85,1.3,42,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6240
P10089,6/29/2025,ongoing,very low count,C,4.06,9.3,23,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,7909
P10090,2/1/2025,successful,not_tested,A,3.62,13.4,34,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9254
P10091,10/12/2025,failed,low count,C,1.41,17.8,45,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,734
P10092,9/15/2025,successful,very low count,,0.66,7.2,44,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2493
P10093,5/9/2025,successful,normal,A,2.56,16.5,36,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8668
P10094,3/29/2025,failed,azoospermia,A,0.61,8.2,38,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5238
P10095,5/5/2025,ongoing,very low count,C,2.13,9,27,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9168
P10096,10/31/2025,successful,not_tested,C,0.25,5.9,31,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4625
P10097,11/19/2024,successful,very low count,,2.2,13.8,23,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8963
P10098,8/26/2025,successful,low count,,3.37,21.4,27,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,415
P10099,3/21/2025,failed,very low count,,3.78,12.1,30,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5797
P10100,11/10/2024,ongoing,normal,,5.2,24.6,41,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,779
P10101,5/2/2025,failed,not_tested,B,1.44,2.4,44,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6216
P10102,2/26/2025,successful,not_tested,C,3.66,19.6,27,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3968
P10103,11/21/2024,successful,normal,,3.31,9.8,44,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6410
P10104,8/19/2025,successful,not_tested,B,0.88,24.2,31,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4761
P10105,8/26/2025,successful,very low count,B,3.7,5.7,28,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3492
P10106,10/25/2024,ongoing,low count,,0.2,4.8,32,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8455
P10107,5/31/2025,successful,low count,A,2.12,3,36,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1618
P10108,8/17/2025,successful,not_tested,A,3.66,6.7,25,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9932
P10109,8/26/2025,successful,very low count,B,2.73,4.1,33,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9011
P10110,11/2/2025,failed,very low count,,2.62,15.4,40,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9240
P10111,8/7/2025,successful,azoospermia,B,5.94,15.1,28,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4366
P10112,2/15/2025,successful,azoospermia,A,0.61,16.1,44,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9494
P10113,3/3/2025,failed,azoospermia,B,3.34,20.2,41,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6324
P10114,11/11/2024,ongoing,normal,C,1.55,8.1,29,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,4507
P10115,1/1/2025,successful,low count,A,3.98,22.5,35,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2889
P10116,3/9/2025,successful,azoospermia,C,3.05,11.5,31,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2686
P10117,10/20/2024,failed,normal,B,1.63,4.1,45,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4209
P10118,6/12/2025,successful,azoospermia,,5.95,9.9,25,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2760
P10119,5/14/2025,ongoing,very low count,C,3.47,3.2,22,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,2704
P10120,5/6/2025,ongoing,azoospermia,,0.95,6.8,42,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8322
P10121,7/31/2025,failed,low count,B,4.43,11.3,34,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9614
P10122,7/4/2025,ongoing,very low count,,3.23,11.4,42,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,4529
P10123,11/17/2024,ongoing,azoospermia,B,4.06,6.5,41,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,979
P10124,3/31/2025,ongoing,not_tested,C,5.82,1.1,36,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,2737
P10125,3/26/2025,ongoing,normal,B,0.19,4.2,30,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,3079
P10126,3/7/2025,successful,low count,B,3.21,5.2,30,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3632
P10127,2/6/2025,failed,azoospermia,,1.59,19.8,43,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6722
P10128,9/5/2025,successful,azoospermia,C,5.37,22.8,27,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6926
P10129,6/24/2025,ongoing,azoospermia,,3.73,2.3,26,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,3886
P10130,10/16/2024,successful,normal,,0.29,21.6,41,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1638
P10131,9/7/2025,ongoing,low count,A,4.15,2.6,38,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,2852
P10132,2/11/2025,failed,very low count,B,1.98,10.4,42,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3685
P10133,2/22/2025,failed,low count,A,4,13.4,28,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2001
P10134,6/23/2025,ongoing,very low count,B,3.26,10.4,26,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,136
P10135,8/27/2025,successful,very low count,B,5.74,3.6,36,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8254
P10136,11/14/2024,failed,very low count,A,3.91,10.4,45,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4273
P10137,12/13/2024,successful,low count,C,3.87,6.9,40,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6997
P10138,8/2/2025,failed,very low count,,3.52,19.4,30,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2906
P10139,5/9/2025,failed,very low count,B,2.77,13.6,42,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5437
P10140,9/1/2025,failed,normal,C,2.39,12.8,28,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,421
P10141,5/29/2025,successful,low count,B,5.24,4,29,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2722
P10142,9/4/2025,ongoing,not_tested,,2.3,5.6,22,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,5246
P10143,10/31/2024,ongoing,not_tested,B,5.74,17,29,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8622
P10144,3/3/2025,successful,low count,,2.41,24.1,24,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1011
P10145,12/16/2024,failed,low count,,1.09,6.4,39,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3660
P10146,8/11/2025,failed,very low count,,5.9,18.2,22,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6891
P10147,11/4/2025,failed,normal,,0.42,18.2,25,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3176
P10148,5/26/2025,failed,very low count,B,1.18,6.9,22,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7739
P10149,10/9/2025,failed,azoospermia,C,3.34,17.6,45,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,8030
P10150,10/30/2024,failed,not_tested,B,0.73,3.6,24,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3106
P10151,12/10/2024,ongoing,low count,,3.53,6.5,39,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6096
P10152,7/9/2025,successful,low count,A,5.23,7.4,41,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3168
P10153,9/26/2025,successful,normal,C,2.27,9.7,25,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,5727
P10154,2/23/2025,ongoing,normal,A,4.23,18,24,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,555
P10155,7/11/2025,successful,very low count,,5.17,6,35,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8612
P10156,10/25/2025,successful,normal,A,0.65,12.4,28,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2668
P10157,2/5/2025,failed,low count,C,4.38,4.7,44,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4716
P10158,12/30/2024,ongoing,very low count,C,0.42,23.5,36,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,3229
P10159,9/28/2025,successful,not_tested,A,1.61,17,43,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,491
P10160,5/24/2025,successful,azoospermia,B,4.71,24.7,39,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3886
P10161,2/13/2025,failed,very low count,,3.81,21.9,40,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4161
P10162,8/19/2025,successful,low count,,1.92,3.2,29,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6845
P10163,4/25/2025,successful,azoospermia,C,1.97,19.2,39,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,591
P10164,12/6/2024,ongoing,not_tested,A,4.37,3.6,43,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,552
P10165,9/3/2025,failed,azoospermia,B,5.8,24.6,45,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3626
P10166,6/26/2025,successful,low count,A,0.64,24.1,40,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7309
P10167,5/25/2025,successful,azoospermia,C,0.52,23,40,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3509
P10168,2/18/2025,successful,azoospermia,A,1.61,21.3,31,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6978
P10169,12/5/2024,failed,azoospermia,A,1.3,21.9,27,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,415
P10170,9/7/2025,successful,very low count,A,2.45,20.7,35,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8328
P10171,10/24/2024,successful,very low count,A,5.16,6.3,35,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,5050
P10172,6/15/2025,successful,normal,B,5.87,22.2,29,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7253
P10173,10/24/2025,successful,low count,,5.36,18.9,40,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3004
P10174,8/6/2025,failed,low count,A,4.89,4.5,26,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2715
P10175,2/3/2025,ongoing,not_tested,A,0.4,3.2,36,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,7858
P10176,12/6/2024,ongoing,not_tested,C,1.13,11.1,37,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,4299
P10177,11/1/2025,ongoing,not_tested,C,1.31,16.2,41,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8414
P10178,10/29/2024,failed,normal,B,1.08,22.7,27,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4045
P10179,11/4/2025,successful,low count,C,3.68,19.8,39,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8841
P10180,11/10/2024,successful,low count,A,4.63,20.3,37,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,5760
P10181,10/6/2025,ongoing,very low count,A,1.26,13,43,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,790
P10182,10/26/2025,failed,not_tested,,2.75,6,34,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9907
P10183,1/27/2025,failed,azoospermia,C,0.67,5.6,23,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9630
P10184,2/18/2025,failed,not_tested,B,1.08,10.9,43,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9402
P10185,1/18/2025,successful,very low count,C,2.64,3,32,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6647
P10186,4/19/2025,ongoing,not_tested,C,3.43,24,37,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6634
P10187,8/27/2025,ongoing,low count,A,5.51,17.1,33,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,7057
P10188,11/3/2024,successful,normal,,5.95,15.6,25,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3167
P10189,6/8/2025,failed,not_tested,C,3.45,8.4,27,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6814
P10190,2/5/2025,successful,very low count,C,2.37,16.7,39,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6766
P10191,5/14/2025,failed,very low count,A,3.27,2,38,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2940
P10192,2/21/2025,successful,very low count,C,5.31,14.1,30,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7861
P10193,2/1/2025,successful,low count,,5.86,6.9,27,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9143
P10194,4/15/2025,failed,normal,C,1.74,18.2,28,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,176
P10195,9/6/2025,ongoing,very low count,C,2.26,21.8,33,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,2406
P10196,9/15/2025,failed,not_tested,B,5.44,8.8,28,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4294
P10197,12/7/2024,failed,low count,,1.75,14,39,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9288
P10198,6/1/2025,failed,not_tested,C,5.18,11.2,33,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5364
P10199,3/8/2025,ongoing,not_tested,A,5.39,14.3,39,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,5817
P10200,3/6/2025,successful,very low count,A,0.79,24,33,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9188
P10201,12/4/2024,failed,normal,B,2.17,11.5,43,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5630
P10202,10/17/2025,failed,low count,B,0.41,6.1,27,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,86
P10203,10/21/2025,failed,normal,B,4.68,6.9,23,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6465
P10204,3/14/2025,ongoing,very low count,B,1.96,4.4,29,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6760
P10205,6/27/2025,failed,normal,A,0.16,18.5,24,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4561
P10206,8/26/2025,failed,azoospermia,,2.75,2.3,24,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,660
P10207,11/4/2025,ongoing,low count,B,3.13,21.7,24,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9293
P10208,1/10/2025,successful,azoospermia,,2.93,24.6,26,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1138
P10209,3/10/2025,failed,low count,A,3.61,11.2,38,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5547
P10210,5/3/2025,successful,low count,C,0.66,2.5,34,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8676
P10211,3/20/2025,failed,not_tested,C,1.94,12.8,40,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5553
P10212,2/3/2025,successful,normal,B,2.52,18.7,34,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8811
P10213,2/19/2025,successful,very low count,,5.34,14.9,32,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,798
P10214,10/3/2025,successful,low count,B,4.63,23.2,44,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4827
P10215,1/23/2025,ongoing,azoospermia,A,2.89,5.4,32,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,4403
P10216,11/12/2025,failed,very low count,A,2.42,4.3,27,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,953
P10217,12/23/2024,ongoing,normal,B,5.47,2.7,32,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,266
P10218,1/5/2025,failed,azoospermia,C,5.46,13.9,31,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7632
P10219,9/3/2025,failed,azoospermia,C,3.49,22.6,43,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3677
P10220,9/25/2025,successful,not_tested,,4.86,2.3,29,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,940
P10221,5/3/2025,failed,not_tested,A,5.45,8.7,25,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,247
P10222,10/17/2025,successful,not_tested,B,1.08,17,39,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8029
P10223,11/8/2024,successful,not_tested,C,2.56,12.2,38,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1054
P10224,11/4/2025,failed,very low count,A,1.25,20.2,35,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6108
P10225,5/24/2025,successful,low count,B,1.07,9.2,28,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,919
P10226,3/28/2025,failed,not_tested,C,1.56,9.8,45,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,631
P10227,10/18/2025,failed,very low count,A,1.09,20.5,23,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7376
P10228,12/19/2024,successful,low count,B,1.38,11.9,25,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,619
P10229,2/12/2025,ongoing,normal,A,3.63,13.4,26,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,230
P10230,12/5/2024,successful,not_tested,B,3.69,12.9,23,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9297
P10231,3/15/2025,failed,low count,A,3.99,19.1,35,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6708
P10232,5/25/2025,failed,normal,A,3.86,13.2,30,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7915
P10233,6/30/2025,successful,azoospermia,C,4.14,18.6,32,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6904
P10234,7/13/2025,failed,not_tested,C,5.07,1.7,44,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2910
P10235,8/16/2025,ongoing,azoospermia,A,2.89,16.6,42,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9017
P10236,4/12/2025,failed,azoospermia,C,4.26,20.5,37,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3930
P10237,5/26/2025,successful,not_tested,C,5.31,22.4,39,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7709
P10238,2/19/2025,successful,azoospermia,B,4.53,4.8,41,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1840
P10239,11/2/2024,ongoing,very low count,A,4.68,20.1,44,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,8876
P10240,10/3/2025,successful,not_tested,A,1.61,24.4,27,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,5870
P10241,5/14/2025,successful,very low count,A,3.33,24.1,26,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1371
P10242,11/2/2024,successful,normal,,3.99,13.7,30,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6589
P10243,12/14/2024,successful,low count,C,2.88,17.7,22,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3805
P10244,3/16/2025,failed,azoospermia,A,3.52,15.3,42,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2536
P10245,7/14/2025,successful,very low count,,2.49,18.7,30,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6090
P10246,9/23/2025,successful,very low count,C,3.63,24.4,31,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1530
P10247,6/4/2025,successful,azoospermia,A,5.65,4.5,23,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6897
P10248,10/4/2025,failed,low count,,2.28,2.7,40,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6650
P10249,5/20/2025,successful,not_tested,B,2.32,12.1,40,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,334
P10250,7/24/2025,successful,very low count,,2.9,18.7,37,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9916
P10251,7/24/2025,successful,azoospermia,,3.14,8.2,22,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6622
P10252,2/15/2025,failed,very low count,,4.84,14.6,32,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4204
P10253,10/8/2025,ongoing,very low count,A,0.35,17.2,25,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9726
P10254,7/11/2025,successful,normal,B,3.67,13.1,44,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8917
P10255,11/3/2024,failed,normal,,1.96,3.6,25,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4245
P10256,4/2/2025,ongoing,normal,A,1.44,18.3,45,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,4524
P10257,10/29/2024,successful,normal,C,5.15,3.8,32,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1376
P10258,6/16/2025,failed,normal,A,1.33,15.5,45,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9391
P10259,3/21/2025,failed,low count,A,1.81,21.1,41,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,8913
P10260,6/21/2025,successful,normal,,2.28,19.7,26,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,2551
P10261,6/19/2025,successful,not_tested,C,3.54,19.5,27,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7036
P10262,10/20/2024,successful,very low count,C,0.39,21.7,43,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,3120
P10263,7/4/2025,successful,not_tested,B,1.51,21.6,23,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,6464
P10264,2/13/2025,successful,azoospermia,C,3.57,12.6,30,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1258
P10265,6/24/2025,successful,azoospermia,C,2.87,15,42,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,805
P10266,6/30/2025,failed,normal,B,3.18,6.6,40,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,8744
P10267,7/19/2025,successful,azoospermia,A,4.38,17.7,22,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8044
P10268,11/10/2024,failed,low count,C,3.29,2.2,32,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2431
P10269,7/11/2025,successful,normal,,1.58,7.6,28,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,5888
P10270,10/22/2025,failed,very low count,B,0.9,3.8,35,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,9617
P10271,11/19/2024,ongoing,not_tested,C,1.03,6.9,29,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6030
P10272,1/6/2025,failed,normal,A,5.72,24.3,43,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5331
P10273,1/20/2025,successful,very low count,A,0.97,2.8,31,D101,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,8492
P10274,1/30/2025,failed,not_tested,C,2.5,19.7,35,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,256
P10275,7/11/2025,successful,normal,A,1.96,23.9,23,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7082
P10276,7/7/2025,failed,normal,A,3.86,16.9,34,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7054
P10277,4/23/2025,successful,low count,C,0.41,18.2,31,D100,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,1420
P10278,12/14/2024,failed,very low count,A,5.21,20,31,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5728
P10279,10/12/2025,ongoing,very low count,B,3.58,20.2,44,D103,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6198
P10280,11/6/2024,failed,normal,C,5.65,18.2,23,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5623
P10281,9/14/2025,ongoing,azoospermia,A,1.37,22.8,45,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,3853
P10282,9/26/2025,failed,azoospermia,C,4.69,5.4,40,D102,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,8895
P10283,5/31/2025,failed,low count,C,1.43,19.3,45,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6526
P10284,9/26/2025,ongoing,low count,,5.3,1.7,42,D102,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9511
P10285,2/18/2025,successful,low count,B,3.38,16.3,29,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,788
P10286,11/9/2024,ongoing,normal,B,1.27,4.1,32,D101,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,9273
P10287,7/10/2025,failed,normal,C,0.35,6.2,37,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,5268
P10288,1/7/2025,successful,normal,B,1.63,5,29,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,7678
P10289,4/12/2025,failed,not_tested,A,0.24,17.7,40,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3389
P10290,9/19/2025,failed,normal,C,4.77,13.3,38,D100,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,2140
P10291,4/18/2025,failed,low count,B,3.5,3.9,26,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6841
P10292,1/14/2025,failed,very low count,A,0.77,9.1,25,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,7184
P10293,6/19/2025,successful,low count,B,3.56,3.9,40,D102,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9275
P10294,3/30/2025,failed,azoospermia,A,0.58,4.1,26,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,4882
P10295,3/12/2025,ongoing,normal,,0.17,2.4,29,D100,"Patient remains under evaluation. Monitoring of follicular response, hormone levels (AMH/FSH), and endometrial thickness is ongoing. Continue current stimulation/monitoring plan and reassess response at next scheduled scan. Pending completion of the cycle, treatment adjustments may be required based on follicular growth and laboratory parameters.",,6709
P10296,4/21/2025,successful,very low count,A,1.48,5.1,44,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,4323
P10297,9/7/2025,failed,not_tested,,1.3,6.4,43,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,3180
P10298,4/17/2025,failed,very low count,B,0.16,3.3,28,D101,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,51
P10299,10/3/2025,successful,azoospermia,B,3.04,10.8,41,D103,"Patient has responded well to ovarian stimulation with adequate follicular development. Embryo transfer was uncomplicated, and implantation appears successful based on biochemical and early clinical indicators. Continue routine antenatal surveillance. Recommend early obstetric scan at 6–7 weeks to confirm viability and monitor for potential early pregnancy complications. No immediate intervention required.",,9461
P10300,8/6/2025,failed,azoospermia,A,0.34,2.8,33,D103,"Cycle outcome indicates no implantation following embryo transfer. Review stimulation protocol and oocyte quality from the previous cycle. Recommend discussion regarding potential protocol optimization, evaluation of endometrial receptivity, and consideration of adjunctive treatments (ERA, PGT-A, or improved lab conditions). Patient should be counseled regarding next-cycle expectations and individualized modifications.",,6150
